financetom
Business
financetom
/
Business
/
Update: BlackRock Q2 Adjusted Earnings, Revenue Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: BlackRock Q2 Adjusted Earnings, Revenue Rise
Jul 15, 2024 6:23 AM

09:03 AM EDT, 07/15/2024 (MT Newswires) -- (Updates with the company's Q2 assets under management in the fifth paragraph.)

BlackRock ( BLK ) reported Q2 adjusted earnings Monday of $10.36 per diluted share, up from $9.28 a year earlier.

Analysts polled by Capital IQ expected $9.96.

Revenue for the quarter ended June 30 was $4.81 billion, up from $4.46 billion a year earlier.

Analysts surveyed by Capital IQ expected $4.79 billion.

The company said its Q2 assets under management increased 13% to about $10.646 trillion from $9.425 trillion a year earlier.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
South Korea consumer inflation eases to 2.9% in April
South Korea consumer inflation eases to 2.9% in April
May 1, 2024
SEOUL (Reuters) -South Korea's consumer inflation eased in April for the first time in three months, official data showed on Thursday, coming in lower than economists' estimates and supporting market expectations for monetary easing in the latter half of the year. The consumer price index stood 2.9% higher than the same month the year before, compared with a rise of...
Australia's Meteoric signs preliminary deal with Neo Performance to supply rare earths
Australia's Meteoric signs preliminary deal with Neo Performance to supply rare earths
May 1, 2024
May 2 (Reuters) - Australia's Meteoric Resources will supply 3,000 metric tonnes of rare earth oxide per year to Toronto-listed Neo Performance Materials ( NOPMF ) under a preliminary agreement, the companies said on Thursday. Neo's rare earth separation factory in Estonia is expected to purchase the rare earth oxide from the initial output of Meteoric's Caldeira project in Brazil....
DBS sees net profit rising this year after Q1 beats forecasts
DBS sees net profit rising this year after Q1 beats forecasts
May 1, 2024
By Yantoultra Ngui SINGAPORE (Reuters) -Singapore's biggest bank DBS Group expects its net profit to grow this year, it said on Thursday, after posting a 15% rise in first quarter net profit that beat expectations, driven by strong total income growth. While geopolitical tensions persist, macroeconomic conditions remain resilient and our franchise is well positioned to capture business opportunities, DBS...
Neurocrine Biosciences' Huntington's disease drug gets FDA approval (April 30)
Neurocrine Biosciences' Huntington's disease drug gets FDA approval (April 30)
May 1, 2024
April 30 (Reuters) - The U.S. Food and Drug Administration (FDA) has approved the granule formulation of Neurocrine Biosciences' ( NBIX ) Ingrezza drug to treat movement disorders associated with Huntington's disease (HD), the company said on Tuesday. Huntington's disease is an inherited condition that causes the progressive breakdown of nerve cells in the brain, resulting in a gradual decline...
Copyright 2023-2026 - www.financetom.com All Rights Reserved